Harnessing the Power of Antibody-Drug Conjugates for the Treatment of Hematologic and Solid Cancer

  • Get clinical insights on the latest antibody-drug conjugate treatments for patients with cancer.
  • Seven live monthly webinars accredited for 1 AMA PRA Category 1 Credit TM
ADC Image
Hurvitz Sara 1

Course Director

Sara Hurvitz, MD, FACP

Director, Breast Cancer Clinical Trials
Program, Division of Hematology-Oncology,
David Geffen School of Medicine, UCLA
Medical Director, Clinical Research Unit,
Jonsson Comprehensive Cancer Center

Agenda

  • Welcome, Introductions, and Pre-session Survey
  • Didactic Presentation of ADCs by Topic/Tumor Type
  • Polling Questions, and Discussion
  • Q&A
  • Conclusion and Post-session Survey

Upcoming  Webinars

May 2, 2022

Levy Benjamin
Antibody-Drug Conjugates in Lung Cancer
Benjamin Levy, MD
Clinical Director of Medical Oncology, Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital Associate Professor of Oncology

June 6, 2022

Connie Lee Batlevi
Recent Advances of Antibody-Drug Conjugates in Hematologic Malignancies

Connie Batlevi, MD, PhD

Inpatient Clinical Director of Lymphoma Service Memorial Sloan Kettering Cancer Center

July 18, 2022

bhavana pothuri
The Promise of Antibody-Drug Conjugates in Gynecologic Malignancies
Bhavana Pothuri, MD
Professor, Department of Obstetrics and Gynecology and Medicine.
Director, Gynecologic Oncology Clinical Trials
NYU Grossman School of Medicine.

August 1, 2022

john marshall1
Antibody-Drug Conjugates for the Treatment of Gastrointestinal Cancers

John Marshall, MD

Chief, Division of Hematology/Oncology, Medstar Georgetown University Hospital
Professor, Medicine and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University
Director, Otto J. Ruesch Center for the Cure of Gastrointestinal Cancer

September 12, 2022

ajay nooka

Multidisciplinary Approaches to Managing ADC-Related Adverse Events

Ajay K. Nooka, MD, MPH, FACP

Associate Professor, Department of Hematology and Medical Oncology
 
Medical Director, Winship Data and Technology Applications Shared Resource
 
Winship Cancer Institute, Emory University School of Medicine

Recordings From Previous Webinars

Antibody-Drug Conjugates in Lung Cancer
Benjamin Levy, MD
Clinical Director of Medical Oncology, Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital l Baltimore, Maryland
Originally Aired May 2, 2022

Leveraging Antibody-Drug Conjugates in Breast Cancer Care

Hope S. Rugo, MD, FASCO

UCSF l San Francisco, California

Originally Aired April 4, 2022
MOA of ADCs and Their Rationale for
Use in Patients with Cancer
Giuseppe Curigliano, MD, PhD
University of Milano | Milano, Italy
Sven de Vos, MD, PhD

UCLA | Los Angeles, California

Originally Aired March 7, 2022

This activity is jointly provided by the University of Nebraska Medical Center and Bio Ascend. This activity is supported by independent educational grants from SeaGen, Inc., ADC Therapeutics, and Gilead Sciences, Inc.